« Previous
Next »
Lung Cancer
Volume 68, Issue 1
, Pages 66-71
, April 2010
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity
References
- FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–1555
- Dual iime point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412–1417
- Fluorine-18-FDG PET imaging is negative in bronchioalveolar carcinoma. J Nucl Med. 1998;39:1016–1020
- Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA. 2001;285:914–924
- Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–1084
- Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–875
- Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32:101–105
- Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. AJR. 2008;191:475–479
- Fluorine-18-fluoro-deoxyglucose uptake in pneumonia. J Nucl Med. 1998;39:1267–1269
PII: S0169-5002(09)00312-2
doi: 10.1016/j.lungcan.2009.05.013
« Previous
Next »
Lung Cancer
Volume 68, Issue 1
, Pages 66-71
, April 2010
